Ładuje się......
Immunological efficacy of glypican-3 peptide vaccine in patients with advanced hepatocellular carcinoma
We have previously conducted a phase I trial to test the efficacy of a glypican-3 (GPC3) peptide vaccine in patients with advanced hepatocellular carcinoma (HCC); however, its immunological mechanism of action remains unclear. Here, we report a pilot study conducted to evaluate the immunological mec...
Zapisane w:
| Wydane w: | Oncoimmunology |
|---|---|
| Główni autorzy: | , , , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Taylor & Francis
2017
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5665076/ https://ncbi.nlm.nih.gov/pubmed/29123959 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1346764 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|